United Kingdom

People: Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

16 Aug 2019
Change (% chg)

$0.40 (+9.30%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Amello, Jason 

Mr. Jason A. Amello has been the Chief Financial Officer, Senior Vice President and Treasurer of Akebia Therapeutics, Inc. He joined Akebia as Senior Vice President, Chief Financial Officer and Treasurer in 2013. Prior to joining Akebia, Mr. Amello served as Executive Vice President, Chief Financial Officer and Treasurer of Ziopharm Oncology, Inc. from 2012 to 2013. From 2000 to 2011, Mr. Amello held various positions at Genzyme Corporation, now Sanofi Genzyme, most recently as Senior Vice President, Corporate Controller and Chief Accounting Officer, and led the Strategic Financial Services group through which he served as a key advisor on all of Genzyme’s mergers and acquisitions and other strategic transactions. Earlier in his career, Mr. Amello spent 10 years in the business advisory and assurance practice of Deloitte, serving in various roles of increasing responsibility through senior manager. Mr. Amello currently serves on the Board of Directors of the New England Baptist Hospital, and is the Chair of the Quality of Care Committee and a member of the Finance and Investment Committee. Mr. Amello also serves on the Board of Directors of Acer Therapeutics Inc. (Nasdaq: ACER), and is a member of the Audit Committee. Mr. Amello holds a B.S. in Accounting from Boston College and is a Certified Public Accountant in the Commonwealth of Massachusetts.

Basic Compensation

Total Annual Compensation, USD 380,438
Restricted Stock Award, USD 278,850
Long-Term Incentive Plans, USD --
All Other, USD 431,735
Fiscal Year Total, USD 1,091,020

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Adrian Adams


John Butler


Jason Amello


Nicole Hadas


Steven Burke


Michel Dahan

As Of  31 Dec 2018